FOXO unit Vector BioSource agrees to buy four Grifols blood collection centers in US asset deal

Reuters2026/07/29 12:33

By:Reuters

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

FOXO’s Vector BioSource signed a definitive agreement to buy assets tied to four U.S. blood collection centers from Grifols Bio Supplies.
Deal structure includes an upfront cash payment, with an earnout tied to EBITDA targets in 2026-2028.
Management expects the acquisition to add more than $10 million of net revenue in the 12 months after closing.
Closing is expected in Q3 or Q4 2026, subject to conditions including required FDA licensure and other regulatory authorizations.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. FOXO Technologies Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202607290830PRIMZONEFULLFEED9800182) on July 29, 2026, and is solely responsible for the information contained therein.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

FOXO unit Vector BioSource agrees to buy four Grifols blood collection centers in US asset deal

You may also like

Crypto prices